Sitryx is building a broad and differentiated pipeline by identifying novel targeted approaches based on how changes in metabolism modulate immune cell function.
|Target ID, validation, hit-to-lead||Lead optimisation|
|Multiple target opportunities|
A number of projects are part of the Eli Lilly development programme.
PTMM: Post-translational modification modulator; MLE: Moonlighting enzyme; OCM: One carbon metabolism; KIN: Kinase